Analyzing ObsEva (NASDAQ:OBSV) and Tharimmune (NASDAQ:THAR)
ObsEva (NASDAQ:OBSV – Get Free Report) and Tharimmune (NASDAQ:THAR – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Institutional and Insider Ownership 17.5% of ObsEva shares are […]
ObsEva (NASDAQ:OBSV – Get Free Report) and Tharimmune (NASDAQ:THAR – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Institutional and Insider Ownership 17.5% of ObsEva shares are […]
